Meet the Experts
Acne may be the most common skin condition in the United States, with various studies estimating 79% to 95% of Americans age 12 to 24 experience at least a minor case, but diagnosing, treating, and managing care for pediatric patients affected by it has never been more complex. Dermatology Times® and its sister brands, Contemporary Pediatrics® and Psychiatric Times™, asked thought leaders across disciplines to share their insights as speakers for this exclusive webinar.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.
